title: Etretinate combined with low-dose prednisolone for an aged patient with adult T-cell leukaemia/lymphoma.
authors.forename: K
authors.initials: K
authors.lastname: Senba-Nakata
authors.forename: Y
authors.initials: Y
authors.lastname: Hatano
authors.forename: K
authors.initials: K
authors.lastname: Ishikawa
authors.forename: T
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Otani
authors.forename: Y
authors.initials: Y
authors.lastname: Takeuchi
authors.forename: K
authors.initials: K
authors.lastname: Katagiri
authors.forename: O
authors.initials: O
authors.lastname: Okamoto
authors.forename: S
authors.initials: S
authors.lastname: Fujiwara
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005050:Etretinate / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage
chemical_list: D005050:Etretinate; D011239:Prednisolone